Tag

Contract Manufacturing

All articles tagged with #contract manufacturing

business1 year ago•0 min saved

Novo Nordisk's Multibillion-Dollar Acquisition of Catalent to Expand Wegovy Production

Novo Holdings, the investment arm of Novo Nordisk’s parent foundation, is acquiring contract manufacturer Catalent for $16.5 billion in an all-cash deal. Catalent, a major player in the contract development and manufacturing world, is heavily involved in producing Novo Nordisk’s top-selling obesity drug Wegovy. As part of the deal, Novo Holdings will sell three Catalent fill-finish sites and related assets to Novo Nordisk, including ones in Italy, Belgium, and Bloomington, IN.

via Endpoints News|

#acquisition #business #catalent

healthcare2 years ago•4 min saved

"Rising Demand for Weight-Loss Drugs Drives Syringe-Filling Firms' Success"

Contract drug manufacturers are investing billions of dollars to expand or build factories that fill the injection pens used for weight-loss drugs like Novo Nordisk's Wegovy. The demand for fill-finish services is increasing as sales of weight-loss drugs, such as Wegovy and Eli Lilly's Mounjaro, soar. Pharmaceutical services companies are racing to secure more of this specialist work, with estimates suggesting that the market for GLP-1 agonists, including oral treatments, could be worth up to $100 billion within a decade. Companies like WuXi Biologics and Catalent are investing in pre-filled syringe capacity, while Novo and Lilly are also increasing their internal capacity. The fill-finish market is predicted to more than double by 2027, driven by the demand for weight-loss drugs and the development of biologic drugs.

via Yahoo Finance|

#contract-manufacturing #glp-1-agonists #healthcare

business2 years ago•7 min saved

Baxter Sells BioPharma Solutions Business for $4.25B.

Baxter International has signed a definitive agreement to sell its BioPharma Solutions (BPS) business to Advent International and Warburg Pincus for $4.25bn in cash. The deal is expected to close in H2 2023, subject to regulatory approvals. BPS has been a leading provider of sterile contract manufacturing solutions, parenteral delivery systems and customized support services to the pharma and biotech industries for decades. As a standalone company and in partnership with Advent and Warburg Pincus, BPS will operate as a premier, independent end-to-end CDMO providing a range of services for clients, from clinical research to commercial deployment.

via Baxter|

#advent-international #baxter-international #biopharma-solutions